{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:15:55Z","timestamp":1786994155989,"version":"build-2736575974"},"reference-count":210,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.metabol.2022.155326","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T23:16:01Z","timestamp":1664579761000},"page":"155326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["Body fatness associations with cancer: evidence from recent epidemiological studies and future directions"],"prefix":"10.1016","volume":"137","author":[{"given":"Susanna C.","family":"Larsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Spyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2022.155326_bb0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2458-9-88","article-title":"The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis","volume":"9","author":"Guh","year":"2009","journal-title":"BMC Public Health"},{"issue":"13","key":"10.1016\/j.metabol.2022.155326_bb0015","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2022.155326_bb0020","series-title":"Diet, nutrition, physical activity and cancer: a global perspective. continuous update project expert report 2018","year":"2018"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/annonc\/mdx819","article-title":"Body mass index and 20 specific cancers: re-analyses of dose-response meta-analyses of observational studies","volume":"29","author":"Choi","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.metabol.2022.155326_bb0030","series-title":"Obesity: preventing and managing the global epidemic: report of a WHO consultation","author":"<collab>WHO Consultation on Obesity (1999: Geneva","year":"2000"},{"issue":"8","key":"10.1016\/j.metabol.2022.155326_bb0035","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer-viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0040","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12916-021-02188-x","article-title":"Causal role of high body mass index in multiple chronic diseases: a systematic review and meta-analysis of Mendelian randomization studies","volume":"19","author":"Larsson","year":"2021","journal-title":"BMC Med"},{"issue":"7","key":"10.1016\/j.metabol.2022.155326_bb0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10654-022-00868-3","article-title":"Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study","volume":"37","author":"Yuan","year":"2022","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0050","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol"},{"issue":"10352","key":"10.1016\/j.metabol.2022.155326_bb0055","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","article-title":"The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019","volume":"400","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0060","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/jnci\/djac061","article-title":"Body size at different ages and risk of six cancers: a mendelian randomization and prospective cohort study","volume":"114","author":"Mariosa","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.metabol.2022.155326_bb0065","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2213-8587(18)30288-2","article-title":"Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK","volume":"6","author":"Bhaskaran","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12916-020-01848-8","article-title":"Associations of six adiposity-related markers with incidence and mortality from 24 cancers-findings from the UK Biobank prospective cohort study","volume":"19","author":"Parra-Soto","year":"2021","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12916-020-01877-3","article-title":"Body mass index and waist circumference in relation to the risk of 26 types of cancer: a prospective cohort study of 3.5 million adults in Spain","volume":"19","author":"Recalde","year":"2021","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.metabol.2022.155326_bb0080","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41416-018-0240-5","article-title":"Excess body weight, weight gain and obesity-related cancer risk in women in Norway: the Norwegian Women and Cancer study","volume":"119","author":"da Silva","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2022.155326_bb0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annepidem.2022.03.013","article-title":"Early adulthood overweight and obesity and risk of premenopausal ovarian cancer, and premenopausal breast cancer including receptor status: prospective cohort study of nearly 500,000 Danish women","volume":"70","author":"Urbute","year":"2022","journal-title":"Ann Epidemiol"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12889-018-5225-z","article-title":"Physical activity, obesity and sedentary behaviour and the risks of colon and rectal cancers in the 45 and up study","volume":"18","author":"Nunez","year":"2018","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ijc.33530","article-title":"Metabolic factors and the risk of small intestine cancers: pooled study of 800 000 individuals in the metabolic syndrome and cancer project","volume":"149","author":"Nagel","year":"2021","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0100","first-page":"1737","article-title":"A large prospective study of risk factors for adenocarcinomas and malignant carcinoid tumors of the small intestine","volume":"24","author":"Cross","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"8","key":"10.1016\/j.metabol.2022.155326_bb0105","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/gutjnl-2016-313622","article-title":"High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men","volume":"67","author":"Hagstrom","year":"2018","journal-title":"Gut"},{"issue":"15","key":"10.1016\/j.metabol.2022.155326_bb0110","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1158\/0008-5472.CAN-19-0459","article-title":"Anthropometric risk factors for cancers of the biliary tract in the biliary tract cancers pooling project","volume":"79","author":"Jackson","year":"2019","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0115","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/aje\/kwz230","article-title":"The association between body mass index and pancreatic cancer: variation by age at body mass index assessment","volume":"189","author":"Jacobs","year":"2020","journal-title":"Am J Epidemiol"},{"issue":"23\u20139","key":"10.1016\/j.metabol.2022.155326_bb0120","article-title":"Adiposity, history of diabetes, and risk of pancreatic cancer in postmenopausal women","volume":"29","author":"Arthur","year":"2019","journal-title":"Ann Epidemiol"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2022.04.032","article-title":"Obesity in relation to renal cell carcinoma incidence and survival in three prospective studies","volume":"82","author":"Graff","year":"2022","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0130","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/cam4.3721","article-title":"Association between blood pressure and BMI with bladder cancer risk and mortality in 340,000 men in three Swedish cohorts","volume":"10","author":"Teleka","year":"2021","journal-title":"Cancer Med"},{"issue":"12","key":"10.1016\/j.metabol.2022.155326_bb0135","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1002\/ijc.31597","article-title":"Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: a prospective pooled cohort study of 800,000 men and women","volume":"143","author":"Teleka","year":"2018","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.metabol.2022.155326_bb0140","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1002\/cam4.3060","article-title":"Lifestyle associated factors and risk of urinary bladder cancer: a prospective cohort study from Norway","volume":"9","author":"Hektoen","year":"2020","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/aje\/kwy249","article-title":"Associations of a healthy lifestyle index with the risks of endometrial and ovarian cancer among women in the Women's Health Initiative study","volume":"188","author":"Arthur","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10654-020-00688-3","article-title":"Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies","volume":"36","author":"van den Brandt","year":"2021","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12916-022-02336-x","article-title":"Adiposity and risk of prostate cancer death: a prospective analysis in UK biobank and meta-analysis of published studies","volume":"20","author":"Perez-Cornago","year":"2022","journal-title":"BMC Med"},{"issue":"7","key":"10.1016\/j.metabol.2022.155326_bb0160","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41416-022-01907-2","article-title":"Anthropometric traits and risk of multiple myeloma: a pooled prospective analysis","volume":"127","author":"Bertrand","year":"2022","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.metabol.2022.155326_bb0165","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjh.18150","article-title":"Body size and risk of non-Hodgkin lymphoma by subtype: a pooled analysis from six prospective cohorts in the United States","volume":"197","author":"Teras","year":"2022","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjh.15904","article-title":"Anthropometric factors and risk of myeloid leukaemias and myelodysplastic syndromes: a prospective study and meta-analysis","volume":"186","author":"Teras","year":"2019","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.metabol.2022.155326_bb0175","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41416-019-0401-1","article-title":"Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individuals","volume":"120","author":"Strongman","year":"2019","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/0284186X.2021.2009562","article-title":"The impact of body mass index and height on risk for primary tumours of the spinal cord, spinal meninges, spinal and peripheral nerves in 1.7 million Norwegian women and men: a prospective cohort study","volume":"61","author":"Gheorghiu","year":"2022","journal-title":"Acta Oncol"},{"issue":"8","key":"10.1016\/j.metabol.2022.155326_bb0185","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/jnci\/djx286","article-title":"Overall and central obesity and risk of lung cancer: a pooled analysis","volume":"110","author":"Yu","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0190","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/ije\/dyac023","article-title":"Association between body mass index and oesophageal cancer mortality: a pooled analysis of prospective cohort studies with >800 000 individuals in the Asia Cohort Consortium","volume":"51","author":"Lee","year":"2022","journal-title":"Int J Epidemiol"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0195","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1158\/1055-9965.EPI-22-0051","article-title":"Association between body mass index and risk of gastric cancer by anatomical and histological subtypes in over 500,000 east and southeast Asian cohort participants","volume":"31","author":"Jang","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"10.1016\/j.metabol.2022.155326_bb0200","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1158\/1055-9965.EPI-19-0389","article-title":"Association of BMI, smoking, and alcohol with multiple myeloma mortality in Asians: a pooled analysis of more than 800,000 participants in the Asia Cohort Consortium","volume":"28","author":"Ugai","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0205","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1089\/thy.2021.0445","article-title":"Body mass index and thyroid cancer risk: a pooled analysis of half a million men and women in the Asia Cohort Consortium","volume":"32","author":"Shin","year":"2022","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0210","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/CEJ.0b013e3283592cef","article-title":"Association of body mass index and risk of death from pancreas cancer in Asians: findings from the Asia Cohort Consortium","volume":"22","author":"Lin","year":"2013","journal-title":"Eur J Cancer Prev"},{"issue":"5","key":"10.1016\/j.metabol.2022.155326_bb0215","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/aje\/kwv089","article-title":"Associations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium","volume":"182","author":"Fowke","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0220","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/ijc.32394","article-title":"Cancer incidence in relation to body fatness among 0.5 million men and women: findings from the China Kadoorie Biobank","volume":"146","author":"Wang","year":"2020","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0225","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41416-018-0124-8","article-title":"Adiposity and risks of colorectal and small intestine cancer in Chinese adults: a prospective study of 0.5 million people","volume":"119","author":"Pang","year":"2018","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0230","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4143\/crt.2021.130","article-title":"Association between the persistence of obesity and the risk of gastric cancer: a nationwide population-based study","volume":"54","author":"Lim","year":"2022","journal-title":"Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0235","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41416-019-0500-z","article-title":"Obesity, abdominal obesity and subsequent risk of kidney cancer: a cohort study of 23.3 million east Asians","volume":"121","author":"Nam","year":"2019","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41416-022-01771-0","article-title":"Impact of overweight and obesity on the risk of hepatocellular carcinoma: a prospective cohort study in 14.3 million Koreans","volume":"127","author":"Jun","year":"2022","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0245","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41416-022-01807-5","article-title":"Lifestyle, body mass index, diabetes, and the risk of pancreatic cancer in a nationwide population-based cohort study with 7.4 million Korean subjects","volume":"127","author":"Park","year":"2022","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.metabol.2022.155326_bb0250","first-page":"5016","article-title":"Cumulative obesity exposure increases the risk of kidney cancer: a longitudinal nationwide cohort study","volume":"11","author":"Park","year":"2021","journal-title":"Am J Cancer Res"},{"issue":"16","key":"10.1016\/j.metabol.2022.155326_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14163880","article-title":"Associations of body mass index and waist circumference with the risk of head and neck cancer: a national population-based study","volume":"14","author":"Kim","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0260","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1089\/thy.2018.0327","article-title":"Metabolic obesity phenotypes and thyroid cancer risk: a cohort study","volume":"29","author":"Kwon","year":"2019","journal-title":"Thyroid"},{"issue":"R1","key":"10.1016\/j.metabol.2022.155326_bb0265","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOL.0000000000000721","article-title":"Mendelian randomization as a tool for causal inference in human nutrition and metabolism","volume":"32","author":"Larsson","year":"2021","journal-title":"Curr Opin Lipidol"},{"issue":"7","key":"10.1016\/j.metabol.2022.155326_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003706","article-title":"Body size and composition and risk of site-specific cancers in the UK Biobank and large international consortia: a mendelian randomisation study","volume":"18","author":"Vithayathil","year":"2021","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0280","first-page":"207","article-title":"Lack of association between modifiable exposures and glioma risk: a mendelian randomization analysis","volume":"22","author":"Saunders","year":"2020","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0285","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.metabol.2022.155326_bb0290","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"issue":"10","key":"10.1016\/j.metabol.2022.155326_bb0295","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","article-title":"Inflammation and cancer: advances and new agents","volume":"12","author":"Crusz","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/j.metabol.2022.155326_bb0300","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.metabol.2022.155326_bb0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.pathol.2.010506.091859","article-title":"Endocrine functions of adipose tissue","volume":"2","author":"Waki","year":"2007","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.metabol.2022.155326_bb0310","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1016\/j.metabol.2017.12.015","article-title":"Inflammation: a key player linking obesity with malignancies","volume":"81","author":"Boutari","year":"2018","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0315","first-page":"334","article-title":"Metabolic messengers: adiponectin","volume":"1","author":"Straub","year":"2019","journal-title":"NatMetab"},{"issue":"18","key":"10.1016\/j.metabol.2022.155326_bb0320","first-page":"18341","article-title":"Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner*","volume":"280","author":"Wang","year":"2005","journal-title":"JBiolChem"},{"issue":"6941","key":"10.1016\/j.metabol.2022.155326_bb0325","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0330","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/er.2011-1015","article-title":"The role of adiponectin in cancer: a review of current evidence","volume":"33","author":"Dalamaga","year":"2012","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0335","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0340","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","article-title":"Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex","volume":"46","author":"Cnop","year":"2003","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.metabol.2022.155326_bb0345","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/s41366-021-00896-1","article-title":"Effects of adiposity on the human plasma proteome: observational and mendelian randomisation estimates","volume":"45","author":"Goudswaard","year":"2021","journal-title":"Int J Obes"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0350","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.orcp.2018.01.005","article-title":"The mechanisms linking obesity to colon cancer: an overview","volume":"12","author":"Tarasiuk","year":"2018","journal-title":"Obes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.metabol.2022.155326_bb0355","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1210\/jc.2003-030214","article-title":"Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies","volume":"88","author":"Gavrila","year":"2003","journal-title":"J Clin Endocrinol Metabol"},{"issue":"8","key":"10.1016\/j.metabol.2022.155326_bb0360","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1517\/13543784.15.8.917","article-title":"Adiponectin: a link between obesity and cancer","volume":"15","author":"Barb","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"issue":"22","key":"10.1016\/j.metabol.2022.155326_bb0365","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/jnci\/dji376","article-title":"Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study","volume":"97","author":"Wei","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0370","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00595-016-1334-4","article-title":"Adiponectin and colorectal cancer","volume":"47","author":"Otani","year":"2017","journal-title":"Surg Today"},{"issue":"22","key":"10.1016\/j.metabol.2022.155326_bb0375","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/jnci\/dji376","article-title":"Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study","volume":"97","author":"Wei","year":"2005","journal-title":"JNatlCancer Inst"},{"issue":"2 Pt 1","key":"10.1016\/j.metabol.2022.155326_bb0380","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1158\/1078-0432.466.11.2","article-title":"Plasma adiponectin and gastric cancer","volume":"11","author":"Ishikawa","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0385","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1186\/s12885-020-07651-1","article-title":"The association of leptin and adiponectin with hepatocellular carcinoma risk and prognosis: a combination of traditional, survival, and dose-response meta-analysis","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.metabol.2022.155326_bb0390","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/ijc.22526","article-title":"Low adiponectin levels are associated with renal cell carcinoma: a case-control study","volume":"120","author":"Spyridopoulos","year":"2007","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0395","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1724600819898696","article-title":"Lower circulating adiponectin is associated with higher risk of renal cell carcinoma: a meta-analysis","volume":"35","author":"Fang","year":"2020","journal-title":"Int J Biol Markers"},{"issue":"6","key":"10.1016\/j.metabol.2022.155326_bb0400","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/1354750X.2019.1634763","article-title":"Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis","volume":"24","author":"Yap","year":"2019","journal-title":"Biomarkers"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0405","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1210\/jc.2002-021209","article-title":"Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece","volume":"88","author":"Petridou","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0410","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1210\/jc.2003-031716","article-title":"Circulating adiponectin and endometrial cancer risk","volume":"89","author":"Dal Maso","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0415","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1159\/000430327","article-title":"Adiponectin and endometrial cancer: a systematic review and meta-analysis","volume":"36","author":"Zeng","year":"2015","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0420","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5937\/jomb0-26452","article-title":"Effects of adiponectin, plasma D-dimer, inflammation and tumor markers on clinical characteristics and prognosis of patients with ovarian cancer","volume":"41","author":"Li","year":"2022","journal-title":"J Med Biochem"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0425","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1210\/jc.2006-1858","article-title":"Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies","volume":"92","author":"K\u00f6rner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"29","key":"10.1016\/j.metabol.2022.155326_bb0430","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011433","article-title":"Serum adiponectin in breast cancer: a meta-analysis","volume":"97","author":"Gu","year":"2018","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.metabol.2022.155326_bb0435","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/gme.0b013e31821e21f5","article-title":"Elevated serum visfatin\/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters","volume":"18","author":"Dalamaga","year":"2011","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0440","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jc.2003-031804","article-title":"Adiponectin and breast cancer risk","volume":"89","author":"Mantzoros","year":"2004","journal-title":"J Clin Endocrinol Metabol"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0445","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1158\/0008-5472.CAN-08-0533","article-title":"Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk","volume":"68","author":"Kaklamani","year":"2008","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.metabol.2022.155326_bb0450","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3748\/wjg.v16.i10.1252","article-title":"Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer","volume":"16","author":"Otake","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0455","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1158\/1078-0432.466.11.2","article-title":"Plasma adiponectin and gastric cancer","volume":"11","author":"Ishikawa","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188460","article-title":"New insights into molecular pathways in colorectal cancer: adiponectin, interleukin-6 and opioid signaling","volume":"1875","author":"\u015awierczy\u0144ski","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2022.155326_bb0465","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-018-3319-7","article-title":"Adiponectin and colon cancer: evidence for inhibitory effects on viability and migration of human colorectal cell lines","volume":"448","author":"Nigro","year":"2018","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0470","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10620-007-9922-1","article-title":"Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line","volume":"53","author":"Konturek","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.metabol.2022.155326_bb0475","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/17474124.2020.1764348","article-title":"Obesity and esophageal cancer: GERD, Barrett's esophagus, and molecular carcinogenic pathways","volume":"14","author":"Schlottmann","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0480","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.mce.2013.08.013","article-title":"Adiponectin inhibits leptin-induced oncogenic signalling in oesophageal cancer cells by activation of PTP1B","volume":"382","author":"Beales","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"10.1016\/j.metabol.2022.155326_bb0485","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1349-7006.2007.00486.x","article-title":"Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2","volume":"98","author":"Ishikawa","year":"2007","journal-title":"Cancer Sci"},{"issue":"5","key":"10.1016\/j.metabol.2022.155326_bb0490","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2010.07.001","article-title":"Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma","volume":"139","author":"Saxena","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0495","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1677\/ERC-07-0065","article-title":"Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-a and RL95 2","volume":"14","author":"Cong","year":"2007","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0500","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ygyno.2015.02.012","article-title":"Adiponectin mediates antiproliferative and apoptotic responses in endometrial carcinoma by the AdipoRs\/AMPK pathway","volume":"137","author":"Zhang","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0505","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/pcan.2011.53","article-title":"Adiponectin inhibits oxidative stress in human prostate carcinoma cells","volume":"15","author":"Lu","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0510","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejca.2010.09.005","article-title":"Molecular mechanisms of leptin and adiponectin in breast cancer","volume":"47","author":"Jard\u00e9","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.metabol.2022.155326_bb0515","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fendo.2020.00066","article-title":"Interfering role of ER\u03b1 on adiponectin action in breast cancer","volume":"11","author":"Naimo","year":"2020","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0520","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1078-0432.CCR-09-1487","article-title":"Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of rho kinase\/IFN-inducible protein 10\/matrix metalloproteinase 9 signaling","volume":"16","author":"Man","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0525","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1158\/0008-5472.CAN-08-2641","article-title":"Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation","volume":"69","author":"Kim","year":"2009","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.metabol.2022.155326_bb0530","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2337\/diabetes.52.5.1104","article-title":"Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation","volume":"52","author":"Juge-Aubry","year":"2003","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0535","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajhg.2013.12.014","article-title":"Causal effects of body mass index on cardiometabolic traits and events: a mendelian randomization analysis","volume":"94","author":"Holmes","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"22","key":"10.1016\/j.metabol.2022.155326_bb0540","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-reactive protein levels in overweight and obese adults","volume":"282","author":"Visser","year":"1999","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.metabol.2022.155326_bb0545","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","article-title":"Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial","volume":"289","author":"Esposito","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0550","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/jnci\/djp459","article-title":"C-reactive protein and the risk of cancer: a mendelian randomization study","volume":"102","author":"Allin","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0555","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12916-022-02322-3","article-title":"Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a Mendelian randomization analysis","volume":"20","author":"Hazelwood","year":"2022","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0560","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/ije\/dyy244","article-title":"Mendelian randomization analysis of C-reactive protein on colorectal cancer risk","volume":"48","author":"Wang","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0565","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12916-021-02193-0","article-title":"Circulating inflammatory cytokines and risk of five cancers: a mendelian randomization analysis","volume":"20","author":"Bouras","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.metabol.2022.155326_bb0570","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.545603","article-title":"Genetically predicted circulating level of C-reactive protein is not associated with prostate cancer risk","volume":"10","author":"He","year":"2020","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.metabol.2022.155326_bb0575","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/ijc.32947","article-title":"Mendelian randomisation analysis of circulating adipokines and C-reactive protein on breast cancer risk","volume":"147","author":"Robinson","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2022.155326_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102956","article-title":"Effects of tumour necrosis factor on cardiovascular disease and cancer: a two-sample Mendelian randomization study","volume":"59","author":"Yuan","year":"2020","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0585","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cmet.2013.08.008","article-title":"Angiogenesis and vascular functions in modulation of obesity, adipose metabolism, and insulin sensitivity","volume":"18","author":"Cao","year":"2013","journal-title":"Cell Metab"},{"issue":"11","key":"10.1016\/j.metabol.2022.155326_bb0590","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s10654-021-00779-9","article-title":"Genetically predicted body composition in relation to cardiometabolic traits: a Mendelian randomization study","volume":"36","author":"Zeng","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.metabol.2022.155326_bb0595","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fgene.2020.00603","article-title":"Causal effects of overall and abdominal obesity on insulin resistance and the risk of type 2 diabetes mellitus: a two-sample mendelian randomization study","volume":"11","author":"Xu","year":"2020","journal-title":"Front Genet"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0600","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.numecd.2020.05.008","article-title":"Causal associations of body mass index and waist-to-hip ratio with cardiometabolic traits among Chinese children: a Mendelian randomization study","volume":"30","author":"Song","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2022.155326_bb0605","first-page":"193","article-title":"Insulin resistance: the clinical spectrum","volume":"6","author":"Mantzoros","year":"1995","journal-title":"Adv Endocrinol Metab"},{"key":"10.1016\/j.metabol.2022.155326_bb0610","article-title":"Fasting insulin and risk of overall and 14 site-specific cancers: evidence from genetic data","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.metabol.2022.155326_bb0615","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/jnci\/djac011","article-title":"Associations between glycemic traits and colorectal cancer: a Mendelian randomization analysis","volume":"114","author":"Murphy","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.metabol.2022.155326_bb0620","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011430","article-title":"Association between markers of glucose metabolism and risk of colorectal cancer","volume":"6","author":"Xu","year":"2016","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.metabol.2022.155326_bb0625","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/ijc.29098","article-title":"Plasma insulin, C-peptide and blood glucose and the risk of gastric cancer: the Japan Public Health Center-based prospective study","volume":"136","author":"Hidaka","year":"2015","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.metabol.2022.155326_bb0630","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1158\/1940-6207.CAPR-16-0141","article-title":"Higher glucose and insulin levels are associated with risk of liver cancer and chronic liver disease mortality among men without a history of diabetes","volume":"9","author":"Loftfield","year":"2016","journal-title":"Cancer Prev Res"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0635","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.27016","article-title":"Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer","volume":"60","author":"Aleksandrova","year":"2014","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0640","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx012","article-title":"The role of obesity, type 2 diabetes, and metabolic factors in pancreatic cancer: a mendelian randomization study","volume":"109","author":"Carreras-Torres","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.metabol.2022.155326_bb0645","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jmedgenet-2019-106200","article-title":"Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer","volume":"57","author":"Lu","year":"2020","journal-title":"J Med Genet"},{"issue":"7","key":"10.1016\/j.metabol.2022.155326_bb0650","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2337\/db20-0084","article-title":"Is type 2 diabetes causally associated with cancer risk? Evidence from a two-sample Mendelian randomization study","volume":"69","author":"Yuan","year":"2020","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.metabol.2022.155326_bb0655","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1158\/1055-9965.EPI-07-0182","article-title":"Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women","volume":"16","author":"Michaud","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"14","key":"10.1016\/j.metabol.2022.155326_bb0660","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/jnci\/djt123","article-title":"Hyperglycemia, insulin resistance, impaired pancreatic beta-cell function, and risk of pancreatic cancer","volume":"105","author":"Wolpin","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0665","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002724","article-title":"The influence of obesity-related factors in the etiology of renal cell carcinoma-a Mendelian randomization study","volume":"16","author":"Johansson","year":"2019","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0670","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv178","article-title":"Evidence of a causal association between insulinemia and endometrial cancer: a Mendelian randomization analysis","volume":"107","author":"Nead","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0675","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1055-9965.EPI-07-2686","article-title":"A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer","volume":"17","author":"Gunter","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.metabol.2022.155326_bb0680","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/15680266113136660067","article-title":"Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies","volume":"8","author":"Karlstad","year":"2013","journal-title":"Curr Drug Saf"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0685","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/bcp.12350","article-title":"Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta-analysis of observational studies","volume":"78","author":"Bu","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MEG.0000000000001001","article-title":"Association between insulin therapy and risk of liver cancer among diabetics: a meta-analysis of epidemiological studies","volume":"30","author":"Liu","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0695","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJM199702273360907","article-title":"Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors","volume":"336","author":"Le Roith","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0700","doi-asserted-by":"crossref","first-page":"T11","DOI":"10.1530\/JME-17-0254","article-title":"IGF-binding proteins","volume":"61","author":"Bach","year":"2018","journal-title":"J Mol Endocrinol"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0705","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000066230","article-title":"The role of the IGF system in cancer: from basic to clinical studies and clinical applications","volume":"63","author":"Moschos","year":"2002","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.metabol.2022.155326_bb0710","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1053\/j.gastro.2019.12.020","article-title":"Circulating levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 associate with risk of colorectal cancer based on serologic and Mendelian randomization analyses","volume":"158","author":"Murphy","year":"2020","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.metabol.2022.155326_bb0715","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1002\/cam4.3345","article-title":"Insulin-like growth factor-1 and site-specific cancers: a Mendelian randomization study","volume":"9","author":"Larsson","year":"2020","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.metabol.2022.155326_bb0720","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/ijc.24927","article-title":"Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies","volume":"126","author":"Rinaldi","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2022.155326_bb0725","article-title":"Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis","author":"Watts","year":"2022","journal-title":"Int J Epidemiol"},{"issue":"12","key":"10.1016\/j.metabol.2022.155326_bb0730","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jnci\/90.12.911","article-title":"Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study","volume":"90","author":"Wolk","year":"1998","journal-title":"JNatlCancer Inst"},{"issue":"5","key":"10.1016\/j.metabol.2022.155326_bb0735","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.annonc.2020.01.066","article-title":"Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with approximately 430 000 women","volume":"31","author":"Murphy","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.metabol.2022.155326_bb0740","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fendo.2018.00117","article-title":"IGF-binding proteins: why do they exist and why are there so many?","volume":"9","author":"Allard","year":"2018","journal-title":"Front Endocrinol"},{"issue":"8","key":"10.1016\/j.metabol.2022.155326_bb0745","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1210\/jc.2009-0614","article-title":"Bioactive insulin-like growth factor-I in obesity","volume":"94","author":"Frystyk","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0750","first-page":"872","article-title":"Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes","volume":"79","author":"Brismar","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0755","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1210\/jc.2003-031349","article-title":"Metabolic, anthropometric, and nutritional factors as predictors of circulating insulin-like growth factor binding protein-1 levels in middle-aged and elderly men","volume":"89","author":"Wolk","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0760","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2265.1993.tb02377.x","article-title":"The regulation of insulin-like growth factor binding protein (IGFBP)-1 during prolonged fasting","volume":"39","author":"Cotterill","year":"1993","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0765","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3181\/00379727-216-44182","article-title":"Insulin-like growth factor binding protein-1: recent findings and new directions","volume":"216","author":"Lee","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"issue":"10","key":"10.1016\/j.metabol.2022.155326_bb0770","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102519","article-title":"Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease","volume":"20","author":"Parida","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0775","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6603051","article-title":"Adiponectin and cancer: a systematic review","volume":"94","author":"Kelesidis","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0780","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1152\/ajpendo.90731.2008","article-title":"APPL1: role in adiponectin signaling and beyond","volume":"296","author":"Deepa","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0785","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2004.12.003","article-title":"AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism","volume":"1","author":"Kahn","year":"2005","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.metabol.2022.155326_bb0790","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1158\/0008-5472.CAN-05-1489","article-title":"Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival","volume":"66","author":"Chaj\u00e8s","year":"2006","journal-title":"Cancer Res"},{"issue":"18","key":"10.1016\/j.metabol.2022.155326_bb0795","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1158\/1078-0432.CCR-07-5074","article-title":"Control of cell growth and survival by enzymes of the fatty acid synthesis pathway in HCT-116 colon cancer cells","volume":"14","author":"Zhan","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0800","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","article-title":"AMP-activated protein kinase induces a p53-dependent metabolic checkpoint","volume":"18","author":"Jones","year":"2005","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0805","doi-asserted-by":"crossref","first-page":"258s","DOI":"10.3945\/ajcn.2009.28449C","article-title":"Adiponectin in insulin resistance: lessons from translational research","volume":"91","author":"Ziemke","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"10.1016\/j.metabol.2022.155326_bb0810","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki","year":"2006","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.metabol.2022.155326_bb0815","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.2337\/dc07-1257","article-title":"Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training","volume":"30","author":"Bl\u00fcher","year":"2007","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0820","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.metabol.2022.155326_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155142","article-title":"Insulin: the master regulator of glucose metabolism","volume":"129","author":"Norton","year":"2022","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0830","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","article-title":"Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress","volume":"40","author":"Sengupta","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2022.155326_bb0835","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.semcancer.2019.07.003","article-title":"mTOR: role in cancer, metastasis and drug resistance","volume":"59","author":"Murugan","year":"2019","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"10.1016\/j.metabol.2022.155326_bb0840","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.metabol.2006.06.017","article-title":"Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women","volume":"55","author":"Weinberg","year":"2006","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0845","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/meta.2002.29997","article-title":"Association between hyperinsulinemia and endogenous androgen levels in peri- and postmenopausal women","volume":"51","author":"Maturana","year":"2002","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0850","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1530\/EJE-16-0834","article-title":"Modulation of SHBG binding to testosterone and estradiol by sex and morbid obesity","volume":"176","author":"Grasa","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0855","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176277","article-title":"Causal relationship between obesity and serum testosterone status in men: a bi-directional Mendelian randomization analysis","volume":"12","author":"Eriksson","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155326_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154193","article-title":"The effect of excess body fat on female and male reproduction","volume":"107","author":"Mintziori","year":"2020","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0865","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1210\/clinem\/dgab713","article-title":"Serum estradiol and 20 site-specific cancers in women: Mendelian randomization study","volume":"107","author":"Larsson","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0870","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","article-title":"Using human genetics to understand the disease impacts of testosterone in men and women","volume":"26","author":"Ruth","year":"2020","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.metabol.2022.155326_bb0875","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/ijc.34116","article-title":"Circulating free testosterone and risk of aggressive prostate cancer: prospective and mendelian randomisation analyses in international consortia","volume":"151","author":"Watts","year":"2022","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.metabol.2022.155326_bb0880","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1053\/j.gastro.2007.03.050","article-title":"The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas","volume":"132","author":"Giovannucci","year":"2007","journal-title":"Gastroenterology"},{"issue":"7122","key":"10.1016\/j.metabol.2022.155326_bb0885","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial ecology: human gut microbes associated with obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.metabol.2022.155326_bb0890","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/00325481.2015.1098519","article-title":"Changes seen in gut bacteria content and distribution with obesity: causation or association?","volume":"127","author":"Bell","year":"2015","journal-title":"Postgrad Med"},{"issue":"7228","key":"10.1016\/j.metabol.2022.155326_bb0895","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","article-title":"A core gut microbiome in obese and lean twins","volume":"457","author":"Turnbaugh","year":"2009","journal-title":"Nature"},{"issue":"7122","key":"10.1016\/j.metabol.2022.155326_bb0900","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0905","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2014.09.053","article-title":"Human genetics shape the gut microbiome","volume":"159","author":"Goodrich","year":"2014","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0910","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41564-020-0743-8","article-title":"Genome-wide associations of human gut microbiome variation and implications for causal inference analyses","volume":"5","author":"Hughes","year":"2020","journal-title":"Nat Microbiol"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0915","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","article-title":"Large-scale association analyses identify host factors influencing human gut microbiome composition","volume":"53","author":"Kurilshikov","year":"2021","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb0920","doi-asserted-by":"crossref","first-page":"14771","DOI":"10.1038\/s41598-020-70724-5","article-title":"Human genetic determinants of the gut microbiome and their associations with health and disease: a phenome-wide association study","volume":"10","author":"Groot","year":"2020","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0925","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1038\/s41366-021-00865-8","article-title":"Obesity-related gut hormones and cancer: novel insight into the pathophysiology","volume":"45","author":"Guzzardi","year":"2021","journal-title":"Int J Obes"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0930","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/07853890601149179","article-title":"Ghrelin, the peripheral hunger hormone","volume":"39","author":"Higgins","year":"2007","journal-title":"Ann Med"},{"issue":"10","key":"10.1016\/j.metabol.2022.155326_bb0935","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105380","article-title":"Role of the ghrelin system in colorectal cancer","volume":"23","author":"Kasprzak","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0940","doi-asserted-by":"crossref","DOI":"10.3390\/biom12040483","article-title":"Ghrelin and cancer: examining the roles of the ghrelin axis in tumor growth and progression","volume":"12","author":"Kotta","year":"2022","journal-title":"Biomolecules"},{"issue":"14","key":"10.1016\/j.metabol.2022.155326_bb0945","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/jnci\/djr194","article-title":"The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas","volume":"103","author":"Murphy","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.metabol.2022.155326_bb0950","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/ijc.32597","article-title":"Serum ghrelin and esophageal and gastric cancer in two cohorts in China","volume":"146","author":"Pritchett","year":"2020","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0955","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074440","article-title":"Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis","volume":"8","author":"Sadjadi","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.metabol.2022.155326_bb0960","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/gutjnl-2011-300653","article-title":"Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma","volume":"61","author":"Murphy","year":"2012","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0965","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1136\/gutjnl-2016-313157","article-title":"Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study","volume":"67","author":"Murphy","year":"2018","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.metabol.2022.155326_bb0970","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/gutjnl-2018-316110","article-title":"Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer","volume":"68","author":"Sundkvist","year":"2019","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.metabol.2022.155326_bb0975","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/ijc.30248","article-title":"The use and interpretation of anthropometric measures in cancer epidemiology: a perspective from the world cancer research fund international continuous update project","volume":"139","author":"Bandera","year":"2016","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb0980","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/ijc.32553","article-title":"Long-term status of predicted body fat percentage, body mass index and other anthropometric factors with risk of colorectal carcinoma: two large prospective cohort studies in the US","volume":"146","author":"Hanyuda","year":"2020","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb0985","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/ije\/dyac025","article-title":"Assessment of causal effects of visceral adipose tissue on risk of cancers: a Mendelian randomization study","volume":"51","author":"Lu","year":"2022","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.metabol.2022.155326_bb0990","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/ije\/dyw129","article-title":"Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer","volume":"45","author":"Gao","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"12","key":"10.1016\/j.metabol.2022.155326_bb0995","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/1055-9965.EPI-19-0036","article-title":"A phenome-wide Mendelian randomization study of pancreatic cancer using summary genetic data","volume":"28","author":"Langdon","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"10.1016\/j.metabol.2022.155326_bb1000","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1158\/1055-9965.EPI-16-0147","article-title":"Genetic risk score Mendelian randomization shows that obesity measured as body mass index, but not waist: hip ratio, is causal for endometrial cancer","volume":"25","author":"Painter","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.metabol.2022.155326_bb1005","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrc3967","article-title":"Adiposity and cancer risk: new mechanistic insights from epidemiology","volume":"15","author":"Renehan","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb1010","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/XCS.0000000000000325","article-title":"Long-term outcomes after adolescent bariatric surgery","volume":"235","author":"de la Cruz-Mu\u00f1oz","year":"2022","journal-title":"J Am Coll Surg"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb1015","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/bjs.11494","article-title":"Role of bariatric surgery in reducing the risk of colorectal cancer: a meta-analysis","volume":"107","author":"Almazeedi","year":"2020","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb1020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SLA.0000000000002525","article-title":"Bariatric surgery and the risk of cancer in a large multisite cohort","volume":"269","author":"Schauer","year":"2019","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.metabol.2022.155326_bb1025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.gastro.2021.03.021","article-title":"Bariatric surgery reduces cancer risk in adults with nonalcoholic fatty liver disease and severe obesity","volume":"161","author":"Rustgi","year":"2021","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb1030","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/apt.16335","article-title":"Systematic review with meta-analysis: bariatric surgery reduces the incidence of hepatocellular carcinoma","volume":"53","author":"Ramai","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"24","key":"10.1016\/j.metabol.2022.155326_bb1035","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1001\/jama.2022.9009","article-title":"Association of bariatric surgery with cancer risk and mortality in adults with obesity","volume":"327","author":"Aminian","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.metabol.2022.155326_bb1040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/bjs\/znac003","article-title":"Effect of bariatric surgery on cancer risk: results from an emulated target trial using population-based data","volume":"109","author":"Lazzati","year":"2022","journal-title":"Br J Surg"},{"issue":"10","key":"10.1016\/j.metabol.2022.155326_bb1045","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.soard.2020.06.008","article-title":"The risk of developing breast, ovarian, and endometrial cancer in obese women submitted to bariatric surgery: a meta-analysis","volume":"16","author":"Ishihara","year":"2020","journal-title":"Surg Obes Relat Dis"},{"issue":"4","key":"10.1016\/j.metabol.2022.155326_bb1050","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/oby.2008.610","article-title":"Cancer incidence and mortality after gastric bypass surgery","volume":"17","author":"Adams","year":"2009","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"10.1016\/j.metabol.2022.155326_bb1055","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/oby.22936","article-title":"Intensive weight loss intervention and cancer risk in adults with type 2 diabetes: analysis of the look AHEAD randomized clinical trial","volume":"28","author":"Yeh","year":"2020","journal-title":"Obesity"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522002049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522002049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:30:00Z","timestamp":1758429000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049522002049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":210,"alternative-id":["S0026049522002049"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155326","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Body fatness associations with cancer: evidence from recent epidemiological studies and future directions","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155326"}}